AtriCure today announced the first use of its newest AtriClip device for minimally invasive concomitant procedures.

Michael Carrel, President and CEO of AtriCure, emphasized the company’s dedication to creating the most effective surgical LAA devices available. He stated that the AtriClip PRO-Mini device is a ...

Building upon the proven technology of AtriCure’s AtriClip platform as the most widely implanted surgical LAA device globally, the AtriClip PRO-Mini device is preloaded with the smallest ...

Michael Carrel, President and CEO of AtriCure, emphasized the company’s dedication to creating the most effective surgical LAA devices available. He stated that the AtriClip PRO-Mini device is a ...

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, ...